Page last updated: 2024-11-07

cortolone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID160499
CHEMBL ID1908042
CHEBI ID3899
MeSH IDM0044581

Synonyms (30)

Synonym
20.alpha.-cortolone
.alpha.-cortolone
3.alpha.,20.alpha.,21-tetrahydroxy-5.beta.-pregnan-11-one
nsc-59872
5.beta.-pregnan-11-one,17,20.alpha.,21-tetrahydroxy-
pregnan-11-one,17,20,21-tetrahydroxy-, (3.alpha.,5.beta.,20s)-
cortolon
5.beta.-pregnane-3.alpha.,20.alpha.,21-tetrol-11-one
nsc59872
cortolone ,
516-42-7
C05481
(3r,5r,8s,9s,10s,13s,14s,17r)-17-[(1s)-1,2-dihydroxyethyl]-3,17-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,12,14,15,16-dodecahydro-1h-cyclopenta[a]phenanthren-11-one
nsc 59872
3j9d9j550a ,
20alpha-cortolone
unii-3j9d9j550a
3alpha,17alpha,20alpha,21-tetrahydroxy-5beta-pregnan-11-one
pregnan-11-one, 3,17,20,21-tetrahydroxy-, (3alpha,5beta,20s)-
5beta-pregnane-3alpha,17,20alpha,21-tetrol-11-one
5beta-pregnan-11-one, 3alpha,17,20alpha,21-tetrahydroxy-
chebi:3899 ,
CHEMBL1908042
cortolone [mi]
alpha-cortolone
5beta-11-oxo-pregnane-3alpha, 11beta ,17, 20s, 21-tetrol
5a,17,20a,21-tetrol-11-one
a-cortolone
DTXSID10904343
Q27106233
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
21-hydroxy steroid
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (2)

PathwayProteinsCompounds
Glucocorticoid & Mineralcorticoid Metabolism013
Biochemical pathways: part I0466

Bioassays (2)

Assay IDTitleYearJournalArticle
AID624619Specific activity of expressed human recombinant UGT2B72000Annual review of pharmacology and toxicology, , Volume: 40Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
AID624618Specific activity of expressed human recombinant UGT2B42000Annual review of pharmacology and toxicology, , Volume: 40Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (16)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (31.25)18.7374
1990's6 (37.50)18.2507
2000's2 (12.50)29.6817
2010's2 (12.50)24.3611
2020's1 (6.25)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 25.14

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index25.14 (24.57)
Research Supply Index3.00 (2.92)
Research Growth Index4.81 (4.65)
Search Engine Demand Index26.67 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (25.14)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (5.56%)5.53%
Reviews1 (5.56%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other16 (88.89%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]